<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05046054</url>
  </required_header>
  <id_info>
    <org_study_id>2021-03-036-001</org_study_id>
    <nct_id>NCT05046054</nct_id>
  </id_info>
  <brief_title>The Effect of Transcutaneous Electrical Nerve Stimulation on Pain During Propofol Injection</brief_title>
  <official_title>The Effect of Transcutaneous Electrical Nerve Stimulation on Pain During Propofol Injection</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kyungpook National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kyungpook National University Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Propofol, an intravenous sedative agent, frequently produces pain during injection. This&#xD;
      study was designed to investigate whether transcutaneous electrical nerve stimulation could&#xD;
      reduce pain during propofol injection.&#xD;
&#xD;
      in minimizing propofol injection pain.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Twenty min after transcutaneous electrical nerve stimulation, the electrodes were removed and&#xD;
      propofol 0.5 mg/kg was administered at the rate of 0.5 ml/sec using syringe pump. Propofol&#xD;
      injection pain was evaluated by a study blinded anesthesiologist using a four point scale:&#xD;
      0=no (negative response to questioning), 1=mild pain (pain reported only in response to&#xD;
      questioning without any behavioral sings), 2=moderate pain (pain reported in response to&#xD;
      questioning and accompanied by a behavioral signs or pain reported spontaneously without&#xD;
      questioning, 3=severe pain (strong vocal response or response accompanied by facial&#xD;
      grimacing, arm withdrawal or tears).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 1, 2021</start_date>
  <completion_date type="Anticipated">October 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">October 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>TENS YW-5000 (YoungWon Medical Co, Korea)</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Investigator)</masking>
    <masking_description>Two electrodes were attached to the radial side of dominant forearm. In the placebo group the TENS device had no current output although the power &quot;on&quot; indicator light remained active.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>pain during propofol injection</measure>
    <time_frame>15 seconds</time_frame>
    <description>Propofol injection pain was evaluated by a study blinded anesthesiologist using a four point scale</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Transcutaneous Electrical Nerve Stimulation</condition>
  <condition>Pain</condition>
  <condition>Propofol Adverse Reaction</condition>
  <arm_group>
    <arm_group_label>transcutaneous electrical nerve stimulation group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Transcutaneous electrical nerve stimulation was givent via two electrodes on the venous cannulation site 20 min before propofol injection</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>No transcutaneous electrical nerve stimulation was not given via two electrodes on the venous cannulation site 20 min before propofol injection</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>transcutaneous electrical nerve stimulation</intervention_name>
    <description>transcutaneous electrical nerve stimulation group received transcutaneous electrical nerve stimulation via two electrodes on the venous cannulation site 20 min before propofol injection</description>
    <arm_group_label>transcutaneous electrical nerve stimulation group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Placebo transcutaneous electrical nerve stimulation</intervention_name>
    <description>Placebo transcutaneous electrical nerve stimulation group received no transcutaneous electrical nerve stimulation via two electrodes on the venous cannulation site 20 min before propofol injection</description>
    <arm_group_label>control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        -&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  American Society of Anesthesiologists physical status classification &gt; 3&#xD;
&#xD;
          -  Patient with a history of allergy to drugs&#xD;
&#xD;
          -  Patient who takes opioid, sedative, anticonvulsant&#xD;
&#xD;
          -  Patient with a history of neurologic disease and psychological disorders&#xD;
&#xD;
          -  patient with skin problem&#xD;
&#xD;
          -  Patient with pacemaker or electric medical device&#xD;
&#xD;
          -  pregnancy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Younghoon Jeon</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kyungpook National University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Younghoon Jeon, Dr</last_name>
    <phone>+82534205863</phone>
    <email>jeon68@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Younghoon Jeon</last_name>
    <phone>+82534205863</phone>
    <email>jeon68@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Kyungpook National university hospital</name>
      <address>
        <city>Daegu</city>
        <zip>41944</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Younghoon Jeon</last_name>
      <phone>+82534205863</phone>
      <email>jeon68@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>September 5, 2021</study_first_submitted>
  <study_first_submitted_qc>September 13, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 16, 2021</study_first_posted>
  <last_update_submitted>October 13, 2021</last_update_submitted>
  <last_update_submitted_qc>October 13, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kyungpook National University Hospital</investigator_affiliation>
    <investigator_full_name>Younghoon Jeon</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

